Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Philip Reigan and Christopher Porter.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.116 |
|
|
|
-
Van Linden AA, Baturin D, Ford JB, Fosmire SP, Gardner L, Korch C, Reigan P, Porter CC. Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality. Mol Cancer Ther. 2013 Dec; 12(12):2675-84.
Score: 0.116